혈액형 검사 시장 : 시장 규모, 점유율, 성장 분석 - 제품별, 검사 유형별, 수법별, 기술별, 용도별, 최종 사용자별, 지역별 산업 예측(2025-2032년)

Global Blood Group Typing Market size was valued at USD 1.89 billion in 2023 and is poised to grow from USD 2.06 billion in 2024 to USD 4.14 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The global blood group typing market is being propelled by technological advancements, rising demand for blood transfusions, and increasing awareness initiatives. The prevalence of chronic diseases like cancer and anemia, which necessitate frequent transfusions, is significantly boosting the need for accurate blood typing. Innovative techniques such as PCR, microarray, and massively parallel sequencing are enhancing the efficiency and accuracy of blood typing processes. Additionally, the expansion of healthcare facilities across both developed and emerging markets is further driving service demand. However, challenges such as high costs, inadequate infrastructure, and ethical concerns may hinder market growth through 2032. The ongoing integration of AI and automation in blood typing holds promise for improving diagnostic precision and turnaround times moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Group Typing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Group Typing Market Segments Analysis

Global Blood Group Typing Market is segmented by Product, Test Type, Technique, Technology, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments and Services & Software. Based on Test Type, the market is segmented into ABO Blood Tests & Rh Typing, Antibody Screening, HLA Typing, Cross-matching Tests and Antigen Typing. Based on Technique, the market is segmented into Assay-based Techniques, PCR-based and Microarray Techniques, Massively Parallel Sequencing and Other Techniques. Based on Technology, the market is segmented into Molecular Typing, Serological Typing, Microarray-based Typing and Next-generation Sequencing. Based on Application, the market is segmented into Blood transfusions, Organ transplants and Diagnostic testing. Based on End User, the market is segmented into Hospitals, Blood Banks, Clinical Laboratories and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Group Typing Market

Globally, governments are enacting policies and programs aimed at encouraging blood donation and enhancing the safety of blood transfusions. Such initiatives play a crucial role in improving the outlook of the blood group typing market by raising awareness and making blood typing services more accessible. Moreover, public health campaigns and subsidies for blood typing equipment are facilitating healthcare facilities' adoption of modern blood typing technologies. As a result, the market is poised for growth as these supportive measures continue to foster a culture of safety and accessibility in blood donation and transfusion practices worldwide.

Restraints in the Global Blood Group Typing Market

A notable restraint in the Global Blood Group Typing market is the variability in test results and the challenges associated with ensuring consistent accuracy. Inconsistencies can arise from various factors, including variations in testing methodologies, quality of reagents, and the skill level of operators. Such discrepancies not only compromise patient safety but also undermine the reliability of blood typing procedures. This inconsistency poses a significant barrier to the widespread adoption of blood group typing solutions and services, potentially limiting their growth and acceptance in the healthcare sector in the years to come.

Market Trends of the Global Blood Group Typing Market

The Global Blood Group Typing market is witnessing a significant shift towards molecular typing techniques, moving away from traditional serological methods. Advanced technologies such as PCR and DNA sequencing are gaining popularity for their precision in identifying rare and weak blood group antigens, making them invaluable in complex scenarios like prenatal testing and in patients with multiple transfusions. This transition not only enhances the accuracy of blood typing but also minimizes risks of alloimmunization and transfusion reactions, positioning these molecular methods as critical components for improved patient outcomes. Consequently, this trend is poised to substantially increase revenue generation potential in the blood typing industry throughout the forecast period.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Startup Analysis

Global Blood Group Typing Market Size by Product & Service & CAGR (2025-2032)

• Market Overview
• Consumables
  • Antisera Reagents
  • Anti-human Globulin Reagents
  • Red Blood Cell Reagents
  • Blood Bank Saline
• Instruments
• Services & Software

Global Blood Group Typing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• ABO Blood Tests & Rh Typing
• Antibody Screening
• HLA Typing
• Cross-matching Tests
• Antigen Typing

Global Blood Group Typing Market Size by Technique & CAGR (2025-2032)

• Market Overview
• Assay-based Techniques
• PCR-based and Microarray Techniques
• Massively Parallel Sequencing
• Other Techniques

Global Blood Group Typing Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Molecular Typing
• Serological Typing
• Microarray-based Typing
• Next-generation Sequencing

Global Blood Group Typing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Blood transfusions
• Organ transplants
• Diagnostic testing

Global Blood Group Typing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Blood Banks
• Clinical Laboratories
• Other End Users

Global Blood Group Typing Market Size & CAGR (2025-2032)

• North America (Product & Service, Test Type, Technique, Technology, Application, End User)
  • US
  • Canada
• Europe (Product & Service, Test Type, Technique, Technology, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Test Type, Technique, Technology, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Test Type, Technique, Technology, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Test Type, Technique, Technology, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bio-Rad Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quotient Limited (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A. (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIAGAST (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Diagnostics (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AXO Science (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MTC Invitro Diagnostics (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Diagnostics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rapid Labs Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NG Biotech (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Demeditec Diagnostics GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sero AS (Norway)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcor Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tulip Group (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medion Grifols Diagnostics AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations